Ken Griffin’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,709
| Closed | -$35.3K | – | 15685 |
|
|
2024
Q2 | $35.3K | Buy |
14,709
+2,633
| +22% | +$9.33K | ﹤0.01% | 12112 |
|
|
2024
Q1 | $59.4K | Sell |
12,076
-48,294
| -80% | -$242K | ﹤0.01% | 12006 |
|
|
2023
Q4 | $252K | Buy |
60,370
+38,810
| +180% | +$293K | ﹤0.01% | 9505 |
|
|
2023
Q3 | $319K | Buy |
21,560
+2
| +0% | +$37 | ﹤0.01% | 9053 |
|
|
2023
Q2 | $629K | Sell |
21,558
-46,090
| -68% | -$1.43M | ﹤0.01% | 7433 |
|
|
2023
Q1 | $1.57M | Buy |
67,648
+185
| +0.3% | +$5K | ﹤0.01% | 5830 |
|
|
2022
Q4 | $971K | Buy |
67,463
+835
| +1% | +$16.1K | ﹤0.01% | 6871 |
|
|
2022
Q3 | $1.6M | Hold |
66,628
| – | – | ﹤0.01% | 6027 |
|
|
2022
Q2 | $1.33M | Sell |
66,628
-895
| -1% | -$19.9K | ﹤0.01% | 6390 |
|
|
2022
Q1 | $2.39M | Sell |
67,523
-425
| -0.6% | -$15.8K | ﹤0.01% | 5708 |
|
|
2021
Q4 | $3.04M | Sell |
67,948
-777
| -1% | -$46.6K | ﹤0.01% | 5305 |
|
|
2021
Q3 | $4.89M | Sell |
68,725
-3,732
| -5% | -$425K | ﹤0.01% | 4341 |
|
|
2021
Q2 | $9.56M | Buy |
72,457
+56,144
| +344% | +$7.02M | ﹤0.01% | 3156 |
|
|
2021
Q1 | $2.19M | Buy |
16,313
+15,414
| +1,715% | +$1.95M | ﹤0.01% | 6186 |
|
|
2020
Q4 | $66K | Buy |
+899
| New | +$66K | ﹤0.01% | 10454 |
|
Other funds holding ASLN
Ken Griffin's ASLN Position: Q3 2024 in Review
Ken Griffin sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 14,709 shares — an estimated $35.3K sold.
Ken Griffin first reported a position in ASLN in Q4 2020 and held it in 15 quarters. The position peaked at $9.56M in Q2 2021. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.
- Ken Griffin reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Ken Griffin sold 14,709 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $35.3K.
- Ken Griffin first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2020 and held it in 15 quarters.
- Ken Griffin's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $9.56M in Q2 2021.
- 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.